Behind the PICS

Causes for cognitive impairment after intensive care explored

People who have been treated in intensive care commonly suffer from residual cognitive impairment, but the reason for this is unknown. Researchers at Karolinska Institutet now link cognitive impairment with lasting inflammation and a potential treatment target.

The results are presented in the scientific journal Intensive Care Medicine

Every year, some 40,000 people are treated in intensive care in Sweden. More than three quarters of these critically ill patients survive, but many suffer subsequent cognitive impairment as part of what is known as the “post-intensive care syndrome” (PICS). The impairments in memory, attention, processing speed and problem solving can remain for years and prevent timely return to normal life and work for those affected.

silhouette of woman holding her forehead from headache

Image source: Unsplash/Matteo Vistocco

“There are no specific treatments as the causes of the condition are unknown,” says Peder Olofsson, researcher at Karolinska Institutet’s Department of Medicine in Solna.

The study, which was led by Olofsson, followed 100 intensive care patients after discharge and found that they had elevated blood levels of the endogenous, pro-inflammatory protein HMGB1 at the time of discharge from hospital and at three and six months afterwards. This supports the hypothesis that some patients suffer from lasting inflammation of unknown origin after intensive care. High HMGB1 levels could also be linked to the attention deficit observed in the patients.

“More studies are needed to understand the connection in detail, but the finding gives us hope that this prolonged functional impairment can be treated with drugs designed to target HMGB1,” says Emily Brück, researcher at the same department and the study’s first author. “Earlier studies have shown that such substances can improve the cognitive function of mice that have survived a serious illness.” 


Source: Karolinska Institutet

26.02.2020

Read all latest stories

Related articles

Photo

After the coma

Prolonged anesthesia 'rewires' the brain

Prolonged anesthesia, also known as medically induced coma, is a life-saving procedure carried out across the globe on millions of patients in intensive medical care units every year. But following…

Photo

Brain inflammation

AI could develop personalised psychosis therapies

A new multicentre study will investigate the link between brain inflammation and psychosis, and use artificial intelligence techniques to identify patients that might benefit most from novel…

Photo

Psychiatry

Leonardo da Vinci: pure genius or ADHD?

Professor Marco Catani suggests the best explanation for Leonardo da Vinci's inability to finish his works is that the great artist may have had Attention Deficit and Hyperactivity Disorder. Leonardo…

Related products

Genrui – FA50

Immunoassays

Genrui – FA50

Genrui Biotech Inc.
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Subscribe to Newsletter